Research.Patient.info
Advanced Colorectal Cancer research hub
2 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
This study, KRYSTAL-10, is for people with advanced bowel cancer that has a specific genetic change (KRAS G12C). It compares a combination of new drugs, MRTX849 and cetuximab, against standard chemotherapy to see which works better for those who have already had initial treatment.
United States · Argentina · Australia - recruitingPhase IV
Can extra tests on cancer samples identify more patients with bowel/colon cancer who should be treated with drugs called anti-EGFR agents?
This UK clinical trial is looking at advanced bowel cancer that started on the right side. Researchers want to find out if testing tumour samples for specific proteins can help doctors identify which patients will benefit from targeted drugs called anti-EGFR therapy alongside their regular chemotherapy.
United Kingdom · England · Northern Ireland